Received Jun 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
both had Covid after receiving Pfizer Covid Shots/had COVID-19; both had Covid after receiving Pfizer Covid Shots/had COVID-19; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "both had Covid after receiving Pfizer Covid Shots/had COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient was calling on behalf of her husband, but she just took Paxlovid, she's in the middle of it because she had COVID-19. They both had Covid after receiving Pfizer Covid Shots. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500122715 Same reporter/drug/event; different patients;